KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Change in Accured Expenses: 2009-2025

Historic Change in Accured Expenses for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $124.0 million.

  • Quest Diagnostics' Change in Accured Expenses rose 1277.78% to $124.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $148.0 million, marking a year-over-year increase of 100.00%. This contributed to the annual value of -$67.0 million for FY2024, which is 21.82% down from last year.
  • Quest Diagnostics' Change in Accured Expenses amounted to $124.0 million in Q3 2025, which was up 195.24% from $42.0 million recorded in Q2 2025.
  • Over the past 5 years, Quest Diagnostics' Change in Accured Expenses peaked at $235.0 million during Q3 2021, and registered a low of -$211.0 million during Q1 2023.
  • Moreover, its 3-year median value for Change in Accured Expenses was $35.0 million (2024), whereas its average is -$818,182.
  • In the last 5 years, Quest Diagnostics' Change in Accured Expenses surged by 2,100.00% in 2022 and then plummeted by 334.38% in 2023.
  • Over the past 5 years, Quest Diagnostics' Change in Accured Expenses (Quarterly) stood at -$1.0 million in 2021, then soared by 2,100.00% to $20.0 million in 2022, then skyrocketed by 780.00% to $176.0 million in 2023, then plummeted by 80.11% to $35.0 million in 2024, then surged by 1,277.78% to $124.0 million in 2025.
  • Its Change in Accured Expenses stands at $124.0 million for Q3 2025, versus $42.0 million for Q2 2025 and -$53.0 million for Q1 2025.